Eric S. Fischer, Ph.D. is the Joseph Deitch Family Chair at Dana-Farber, the director of the Chemical Biology Program at Dana-Farber Cancer Institute, Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School, and Co-Director of the Center for Therapeutics Discovery. Dr. Fischer trained in structural biology and biochemistry at the University of Basel and conducted his doctorate studies at the Friedrich Miescher Institute for Biomedical Research. His lab at Dana-Farber focusses on the understanding of fundamental processes in ubiquitin signaling, and the molecular basis of ubiquitin ligase activity, targeting and regulation. His lab seeks to leverage this understanding for the development of novel therapeutic approaches, such as targeted protein degradation. He and his lab have significantly contributed to our understanding of small molecule mediated protein degradation, and its widespread application in academia and industry.